2 unknown, 1 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Completed 1 |
Follow olinvacimab: new trials by email Literature Review of olinvacimab trials Research Report on olinvacimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma TTAC-0001 and pembrolizumab combination - Recurrent Glioblastoma | Phase 1 | Unknown | PharmAbcine | 9 | 2019-01-16 | 2022-08-17 |
| TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer TTAC-0001 and pembrolizumab combination - Triple Negative Breast Cancer | Phase 1 | Unknown | PharmAbcine | 11 | 2019-01-03 | 2022-08-17 |
| Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer Tanibirumab - Advanced Cancer, Metastatic Cancer | Phase 1 | Completed | PharmAbcine | 26 | 2011-11-01 | 2014-01-29 |
Glioblastoma (1) · Neoplasm Metastasis (1) · Triple Negative Breast Neoplasms (1)
PharmAbcine (3)
Australia (2) · South Korea (1)